Relapsing Forms of Multiple Sclerosis: Clinical Trials

1 trial for Relapsing Forms of Multiple Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Withdrawn 1

Follow Relapsing Forms of Multiple Sclerosis: new trials by email Literature Review of Relapsing Forms of Multiple Sclerosis trials Research Report on Relapsing Forms of Multiple Sclerosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)
dimethyl fumarate, Placebo - Relapsing-Remitting Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
Phase 3WithdrawnBiogen2016-05-012016-04-13

Narrower conditions

Multiple Sclerosis (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Immune System Diseases (1)  ·  Nervous System Diseases (1)

Interventions

Dimethyl Fumarate (1)

Sponsors

Biogen (1)

NIH funding

2014 (1)